On March 12, 2025, The Centers for Medicare and Medicaid Services (CMS) Innovation Center announced the early termination of four Medicare payment models and the cancellation of two planned models, citing expected budget savings of approximately $750 million.

On February 18, 2025, the United States Court of Appeals for the First Circuit issued its decision in United States v. Regeneron Pharmaceuticals, Inc. adopting the more stringent “but for” causation standard for alleged violations of the False Claims Act (FCA) based on violations of the Anti-Kickback Statute (AKS).

On March 4, 2025, in response to a lawsuit by several civil rights organizations and individuals against the federal government’s policy directives on gender-affirming care, a federal court issued a partial block of Executive Order 14187 titled “Protecting Children from Chemical and Surgical Mutilation” and Executive Order 14168 titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government.”